Adjuvant chemotherapy might be necessary for breast cancer patients at stage I. The number of patients with stage III disease might be insufficient for the estimation of statistical difference in this study, large numbers of patients with stage III disease might be necessary in future to conclude the significance of E-cadherin in patients with stage III disease. The gene discussed is CDH1; the disease is breast carcinoma.